These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 25550842)
1. Dual high expression of STAT3 and cyclinD1 is associated with poor prognosis after curative resection of esophageal squamous cell carcinoma. Li H; Xiao W; Ma J; Zhang Y; Li R; Ye J; Wang X; Zhong X; Wang S Int J Clin Exp Pathol; 2014; 7(11):7989-98. PubMed ID: 25550842 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of CyclinD1 and E-Cadherin in patients with esophageal squamous cell carcinoma: multiinstitutional retrospective analysis. Research Committee on Malignancy of Esophageal Cancer, Japanese Society for Esophageal Diseases. J Am Coll Surg; 2001 Jun; 192(6):708-18. PubMed ID: 11400964 [TBL] [Abstract][Full Text] [Related]
3. Expression of activated signal transducer and activator of transcription-3 as a predictive and prognostic marker in advanced esophageal squamous cell carcinoma. Huang C; Wang L; Yang X; Lai L; Chen D; Duan C World J Surg Oncol; 2015 Nov; 13():314. PubMed ID: 26553224 [TBL] [Abstract][Full Text] [Related]
4. [Expression and clinical significance of COX-2, p-Stat3, and p-Stat5 in esophageal carcinoma]. Liu JR; Wang Y; Zuo LF; Li FL; Wang Y; Liu JL Ai Zheng; 2007 May; 26(5):458-62. PubMed ID: 17672932 [TBL] [Abstract][Full Text] [Related]
5. Prognostic values of STAT3 and HIF-1α in esophageal squamous cell carcinoma. Zhao X; Tang YP; Wang CY; Wu JX; Ye F Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3351-3357. PubMed ID: 31081089 [TBL] [Abstract][Full Text] [Related]
6. [Overexpression of p-Stat3 and Mcl-1, and their correlation with differentiation and apoptotic resistance in esophageal squamous cell carcinoma]. Huo YQ; Ruan X; DU XL; Shang L; Cai Y; Xu X; Wang MR; Zhang Y; Fu SB Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):579-84. PubMed ID: 24314214 [TBL] [Abstract][Full Text] [Related]
7. High expression of Y-box-binding protein-1 is associated with poor survival in resectable esophageal squamous cell carcinoma. Li Y; Wen ZS; Yang HX; Luo RZ; Zhang Y; Zhang MF; Wang X; Jia WH Ann Surg Oncol; 2011 Nov; 18(12):3370-6. PubMed ID: 21630125 [TBL] [Abstract][Full Text] [Related]
9. CyclinD1, p53, E-cadherin, and VEGF discordant expression in paired regional metastatic lymph nodes of esophageal squamous cell carcinoma: a tissue array analysis. Luo KJ; Hu Y; Wen J; Fu JH J Surg Oncol; 2011 Sep; 104(3):236-43. PubMed ID: 21480261 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of cyclinD1 amplification and the co-alteration of cyclinD1/pRb/ppRb in patients with esophageal squamous cell carcinoma. Wang MT; Chen G; An SJ; Chen ZH; Huang ZM; Xiao P; Ben XS; Xie Z; Chen SL; Luo DL; Tang JM; Lin JY; Zhang XC; Wu YL Dis Esophagus; 2012; 25(7):664-70. PubMed ID: 22150974 [TBL] [Abstract][Full Text] [Related]
11. The overexpression of DBC1 in esophageal squamous cell carcinoma correlates with poor prognosis. Kim SH; Kim JH; Yu EJ; Lee KW; Park CK Histol Histopathol; 2012 Jan; 27(1):49-58. PubMed ID: 22127596 [TBL] [Abstract][Full Text] [Related]
12. Prognostic relevance of Id-1 expression in patients with resectable esophageal squamous cell carcinoma. Luo KJ; Wen J; Xie X; Fu JH; Luo RZ; Wu QL; Hu Y Ann Thorac Surg; 2012 May; 93(5):1682-8. PubMed ID: 22480390 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of pituitary tumor transforming gene (PTTG) is associated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma. Zhang J; Yang Y; Chen L; Zheng D; Ma J Acta Histochem; 2014 Apr; 116(3):435-9. PubMed ID: 24176776 [TBL] [Abstract][Full Text] [Related]
14. Shp2 Inhibits Proliferation of Esophageal Squamous Cell Cancer via Dephosphorylation of Stat3. Qi C; Han T; Tang H; Huang K; Min J; Li J; Ding X; Xu Z Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085101 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of p27(Kip1) and CyclinD1 expression in esophageal cancer. Itami A; Shimada Y; Watanabe G; Imamura M Oncology; 1999 Nov; 57(4):311-7. PubMed ID: 10575318 [TBL] [Abstract][Full Text] [Related]
16. A three-protein signature and clinical outcome in esophageal squamous cell carcinoma. Cao HH; Zhang SY; Shen JH; Wu ZY; Wu JY; Wang SH; Li EM; Xu LY Oncotarget; 2015 Mar; 6(7):5435-48. PubMed ID: 25605255 [TBL] [Abstract][Full Text] [Related]
17. Tyrosine-protein phosphatase nonreceptor type 12 is a novel prognostic biomarker for esophageal squamous cell carcinoma. Cao X; Li Y; Luo RZ; He LR; Yang J; Zeng MS; Wen ZS Ann Thorac Surg; 2012 May; 93(5):1674-80. PubMed ID: 22429674 [TBL] [Abstract][Full Text] [Related]
18. Prolyl isomerase Pin1 expression predicts prognosis in patients with esophageal squamous cell carcinoma and correlates with cyclinD1 expression. Fukuchi M; Fukai Y; Kimura H; Sohda M; Miyazaki T; Nakajima M; Masuda N; Tsukada K; Kato H; Kuwano H Int J Oncol; 2006 Aug; 29(2):329-34. PubMed ID: 16820873 [TBL] [Abstract][Full Text] [Related]
19. Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis. Jia Y; Wang N; Wang J; Tian H; Ma W; Wang K; Tan B; Zhang G; Yang S; Bai B; Cheng Y Ann Surg Oncol; 2014 Jan; 21(1):329-36. PubMed ID: 23982252 [TBL] [Abstract][Full Text] [Related]
20. Identification of LETM1 as a marker of cancer stem-like cells and predictor of poor prognosis in esophageal squamous cell carcinoma. Yang Z; Ni W; Cui C; Qi W; Piao L; Xuan Y Hum Pathol; 2018 Nov; 81():148-156. PubMed ID: 30031102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]